+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

High frequency transformation of the Amphotericin-producing bacterium Streptomyces nodosus

High frequency transformation of the Amphotericin-producing bacterium Streptomyces nodosus

Journal of Microbiological Methods 55(1): 273-277, October

This study has investigated DNA transformation in the Amphotericin-producing organism Streptomyces nodosus. Amphotericin B is an antifungal drug with severe side effects in humans and the availability of structural variants would aid investigations into the mode of action and cytotoxity of the drug. Analogs of related polyketide drugs have been rapidly made by genetic engineering of biosynthetic genes; however, this requires the introduction of foreign DNA into the host. Protocols for protoplast formation and regeneration were established; however, preparations were recalcitrant to DNA uptake. Electroporation-mediated methodologies also were not successful. Intergeneric conjugal transfer of DNA from E. coli demonstrated transformation efficiencies of 5 x 10(-5) exconjugants generated per recipient. Use of DNA methylation-impaired E. coli donor strains resulted in 100-fold higher transformation efficiencies, indicating that DNA methylation recognition systems are operable in the organism. This methodology will enable genetic and biochemical analysis of the gene cluster responsible for making Amphotericin B.

(PDF emailed within 0-6 h: $19.90)

Accession: 010749532

Download citation: RISBibTeXText

PMID: 14500018

DOI: 10.1016/s0167-7012(03)00160-x

Related references

Streptomyces nodosus sp. n., the amphotericin-producing organism. Journal of Bacteriology 85: 436-439, 1963

An amphotericin b producing organism streptomyces nodosus strain as 4.1006. Weishengwu Xuebao 18(4): 312-316, 1978

Production of amphotericin B-14C by Streptomyces nodosus fermentation, and preparation of the amphotericin B-14C-methyl-ester. Journal of Antibiotics 27(3): 155-160, 1974

Natural variation of actinomyces streptomyces nodosus producing amphotericin with respect to antibiotic production polyenes anti bacterial non polyenes. Antibiotiki (Moscow) 13(4): 297-303, 1968

High frequency transformation of the industrial erythromycin-producing bacterium Saccharopolyspora erythraea. Biotechnology Letters 30(2): 357-361, 2007

Production of amphotericin b carbon 14 by streptomyces nodosus fermentation and preparation of the amphotericin b carbon 14 methyl ester. Journal of Antibiotics (Tokyo) 27(3): 155-160, 1974

In situ detection of antibiotic amphotericin B produced in Streptomyces nodosus using Raman microspectroscopy. Marine Drugs 12(5): 2827-2839, 2014

Amphotericin biosynthesis in Streptomyces nodosus: deductions from analysis of polyketide synthase and late genes. Chemistry & Biology 8(7): 713-723, 2001

Use of acridine yperite in selection of actinomyces nodosus producing amphotericin b. Antibiotiki (Moscow) 24(1): 3-6, 1979

Isolation and characterisation of amphotericin B analogues and truncated polyketide intermediates produced by genetic engineering of Streptomyces nodosus. Organic & Biomolecular Chemistry 8(16): 3758-3770, 2010

Phosphomannose isomerase and phosphomannomutase gene disruptions in Streptomyces nodosus: impact on amphotericin biosynthesis and implications for glycosylation engineering. Metabolic Engineering 11(1): 40-47, 2008

Cytomorphology of natural mutants of Actinomyces nodosus Trejo producing amphotericin B under submerged conditions. Antibiotiki 17(3): 235-239, 1972

The morphology of sporophores and spores in spontaneous mutants of the amphotericin producing organism actinomyces nodosus. Antibiotiki (Moscow) 15(9): 785-789, 1970